Long-Term Clinical Benefit of Sirolimus-Eluting Stents in Patients With In-Stent Restenosis. Results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) Study

Journal of the American College of Cardiology

Volumn 52, Issue 20, 2008, Pages 1621-1627

  Alfonso, Fernando ^a   Pérez Vizcayno, María José ^a   Hernández, Rosana ^a   Bethencourt, Armando ^b   Martí, Vicens ^c   López Mínguez, José R ^d   Angel, Juan ^c   Iñiguez, Andrés ^e   Morís, César ^f   Cequier, Angel ^c   Sabaté, Manel ^c   Escaned, Javier ^a   Jiménez Quevedo, Pilar ^a   Bañuelos, Camino ^a   Suárez, Alfonso ^a   Macaya, Carlos ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b Unit of Surgery and Internal Medicine   (Spain)

^c University Hospital   (Spain)

^d HOSPITAL INFANTA CRISTINA   (Spain)

^e University Hospital Meixoeiro   (Spain)

^f University Hospital   (Spain)

Author keywords

angiography; angioplasty; restenosis; sirolimus eluting stents

Indexed keywords

CLOPIDOGREL; RAPAMYCIN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; THROMBOSIS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBIOTICS, ANTINEOPLASTIC; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FOLLOW-UP STUDIES; HUMANS; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SIROLIMUS; TICLOPIDINE;

EID: 55249092504     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.08.025     Document Type: Article

References (15)

1. Kastrati A., Mehilli J., von Beckerath N., et al. Sirolimus-eluting stent or paclitaxel-eluting stent versus balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293 (2005) 165-171
2. Alfonso F., Perez-Vizcayno M.J., Hernandez R., et al. A randomized comparison of sirolimus- eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS II) trial. J Am Coll Cardiol 47 (2006) 2152-2160
3. Holmes Jr. D.R., Teirstein P., Satler L., et al. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA 295 (2006) 1264-1273
4. Stone G.W., Ellis S.G., O'Shaughnessy C.D., et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 295 (2006) 1253-1263
5. Stone G.W., Moses J.W., Ellis S.G., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356 (2007) 998-1008
6. Lagerqvist B., James S.K., Stenestrand U., et al. Long-term outcome with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
7. Beohar N., Davidson C.J., Kip K.E., et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 297 (2007) 1992-2000
8. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end-points in coronary stent trials. A case for standardized definitions. Circulation 115 (2007) 2344-2351
9. Tu J.V., Bowen J., Chiu M., et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 357 (2007) 1393-1402
10. Tsimikas S. Drug-eluting stents and late adverse clinical outcomes lessons learned, lessons awaited. J Am Coll Cardiol 47 (2006) 2112-2115
11. Waksman R., Ajani A.E., White L., et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 109 (2004) 340-344
12. Lee S.W., Park S.W., Park D.W., et al. Comparison of six-month angiographic and three-year outcomes after sirolimus-eluting stent implantation versus brachytherapy for bare-metal in-stent restenosis. Am J Cardiol 100 (2007) 425-430
13. Sheiban I., Chiribi A., Beninati S., et al. Sirolimus-eluting stents for the treatment of bare-metal in-stent restenosis: a long-term follow-up. J Invas Cardiol 19 (2007) 174-180
14. Alfonso F., Cequier A., Angel J., et al. Value of the American College of Cardiology/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis. Am Heart J 151 (2006) 681.e1-681.e9
15. Stone G.W., Ellis S.G., Colombo A., et al. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation. Circulation 115 (2007) 2842-2847